Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious disease: changing antibiotic susceptibility.

Regis P Kowalski1, Lisa M Karenchak, Eric G Romanowski

  • 1Department of Ophthalmology, University of Pittsburgh, School of Medicine, Charles T. Campbell Ophthalmic Microbiology Laboratory, Eye and Ear Institute, Pittsburgh, PA, USA. Kowalskirp@msx.upmc.edu

Ophthalmology Clinics of North America
|April 10, 2003
PubMed
Summary

Older antibiotics remain effective for eye infections, but resistance is growing. Judicious use of current antibiotics is crucial to preserve their effectiveness against emerging bacterial resistance in ophthalmology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ceftazidime for Gram-negative bacterial keratitis.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2026
Same author

Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis.

Investigative ophthalmology & visual science·2026
Same author

Cefiderocol Is Effective In Vitro Against Numerous Gram-Negative Species Isolated from Keratitis Patients.

Antibiotics (Basel, Switzerland)·2026
Same author

Besifloxacin-eluting contact lens with sustained drug delivery and enhanced bioavailability.

International journal of pharmaceutics: X·2026
Same author

Overcoming Antimicrobial Resistance in Bacterial Keratitis With an Antibiotic-Eluting Contact Lens.

Investigative ophthalmology & visual science·2025
Same author

Eying up predatory bacteria: living antimicrobials for ocular infections.

Current opinion in ophthalmology·2025

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Ophthalmology utilizes various antibiotics for bacterial infections.
  • Reduced systemic use of older antibiotics has decreased resistance, preserving their efficacy for ocular infections.
  • Recurrent ophthalmic infections, such as blepharitis, can develop resistance due to repeated exposure to specific antibiotics like erythromycin.

Purpose of the Study:

  • To review the current landscape of antibiotic resistance in ophthalmic infections.
  • To highlight the emergence of resistance trends in common ocular pathogens.
  • To emphasize the importance of judicious antibiotic use in ophthalmology.

Main Methods:

  • Review of current literature on antibiotic resistance patterns in ophthalmology.

Related Experiment Videos

  • Analysis of resistance trends for key ocular pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa.
  • Discussion of therapeutic strategies for managing antibiotic resistance in eye infections.

    • Main Results:

    • Older antibiotics are likely to retain efficacy for ophthalmic infections due to reduced systemic use.
    • Emerging resistance trends observed in Staphylococcus aureus to second-generation fluoroquinolones.
    • New resistance patterns identified in Pseudomonas aeruginosa, necessitating careful antibiotic selection.
    • Recurrent infections and those treated with broad-spectrum agents require routine culturing to guide appropriate therapy.

    Conclusions:

    • Judicious use of current ophthalmic antibiotics is essential to prevent further resistance development.
    • Routine culturing is recommended for recurrent or broadly treated eye infections to ensure effective therapy.
    • Preserving the potency of existing antibiotics is critical for the future management of bacterial eye infections.